High-dose (HDS) chemotherapy in multiple myeloma: Residual tumor cells are detectable in PBPC and BM cell harvests and after single or double autografting.

被引：0
|
作者：
Corradini, P [1 ]
Astolfi, M [1 ]
Ladetto, M [1 ]
Campana, S [1 ]
Comoglio, F [1 ]
Tarella, C [1 ]
Boccadoro, M [1 ]
Pileri, A [1 ]
机构：
[1] UNIV TURIN,AZ OSPED S GIOVANNI BATTISTA,DIP MED & ONCOL SPERIMENTALE,DIV EMATOL,TURIN,ITALY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：810 / 810
页数：1
相关论文
共 50 条
  • [1] HIGH-DOSE CHEMORADIOTHERAPY IN MULTIPLE-MYELOMA - RESIDUAL TUMOR-CELLS ARE DETECTABLE IN BONE-MARROW AND PERIPHERAL-BLOOD CELL HARVESTS AND AFTER AUTOGRAFTING
    CORRADINI, P
    VOENA, C
    ASTOLFI, M
    LADETTO, M
    TARELLA, C
    BOCCADORO, M
    PILERI, A
    BLOOD, 1994, 84 (10) : A399 - A399
  • [2] HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY IN MULTIPLE-MYELOMA - RESIDUAL TUMOR-CELLS ARE DETECTABLE IN BONE-MARROW AND PERIPHERAL-BLOOD CELL HARVESTS AND AFTER AUTOGRAFTING
    CORRADINI, P
    VOENA, C
    ASTOLFI, M
    LADETTO, M
    TARELLA, C
    BOCCADORO, M
    PILERI, A
    BLOOD, 1995, 85 (06) : 1596 - 1602
  • [3] High-dose therapy with peripheral blood progenitor cell (PBPC) autografting in multiple myeloma (MM)
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Fruehauf, S
    Hohaus, S
    Wannenmacher, M
    Haas, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 404 - 404
  • [4] High-dose (HDS) chemotherapy and PBPC autografting in low- and intermediate-grade B-cell lymphomas: Analysis of minimal residual disease and molecular follow-up.
    Corradini, P
    Astolfi, M
    Caracciolo, D
    Bondesan, P
    Cherasco, C
    Pileri, A
    Tarella, C
    BLOOD, 1995, 86 (10) : 3229 - 3229
  • [5] High-dose (HDS) chemotherapy and PBPO autografting in follicular and mantle cell lymphomas: Analysis of minimal residual disease and molecular follow-up
    Corradini, P
    Astolfi, M
    Caracciolo, D
    Bondesan, P
    Cherasco, C
    Pileri, A
    Tarella, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1383 - 1383
  • [6] Collection of peripheral blood progenitor cells (PBPC) in patients with multiple myeloma (MM) after high-dose cyclophosphamide (HDCYC).
    Mant, G
    Thiessard, F
    Faberes, C
    ConyMakhoul, P
    Boiron, JM
    Pigneux, A
    Vezon, G
    Bernard, P
    Broustet, A
    Salmi, R
    Reiffers, J
    BLOOD, 1996, 88 (10) : 3681 - 3681
  • [7] PCR-based evaluation of residual tumor cells after high-dose chemotherapy: Comparison between peripheral blood progenitor cells and bone marrow harvests
    Corradini, P
    Astolfi, M
    Voena, C
    Cherasco, C
    Ladetto, M
    Boccadoro, M
    Tarella, C
    Pileri, A
    BLOOD, 1996, 88 (10) : 3731 - 3731
  • [8] MOBILIZATION OF PERIPHERAL STEM-CELLS AFTER HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA
    WUNDER, E
    SOVALAT, H
    LIANG, H
    EISENMANN, JC
    HENON, P
    INTERNATIONAL JOURNAL OF CELL CLONING, 1992, 10 : 38 - 40
  • [9] Management of residual tumor after salvage high-dose chemotherapy in patients with germ cell tumors
    Rick, O
    Bokemeyer, C
    Schirren, J
    Braun, T
    Weissbach, L
    Siegert, W
    Beyer, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S193 - S193
  • [10] Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
    Rick, O
    Bokemeyer, C
    Weinknecht, S
    Schirren, J
    Pottek, T
    Hartmann, IT
    Braun, T
    Rachud, B
    Weissbach, L
    Hartmann, M
    Siegert, W
    Beyer, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3713 - 3719
12345